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Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is a frequent cause of infection in the 
pediatric population. Initially, MRSA was restricted to hospitals; however, outbreaks in the community 
among people without health care-related risk factors have been reported worldwide. Currently, MRSA 
is a frequent cause of both hospital and community-associated infections.
Objective: To describe the relationships between the molecular characteristics of MRSA isolates 
(staphylococcal cassette chromosome mec (SCCmec) type and Panton-Valentine leukocidin (PVL) 
carriage) and the characteristics of infection (the origin and localization of infection) in pediatric patients 
at the Hospital Universitario de Santander in Bucaramanga, Colombia.
Materials and methods: A total of 43 MRSA isolates were obtained from hospitalized pediatric patients. 
SCCmec typing (I-V), SCCmec IV subtyping and PVL carriage were determined and related to the 
clinical characteristics. 
Results: Among the MRSA isolates studied, SCCmec IVc was present in 77%, followed by 16% for 
SCCmec I and 2% for SCCmec IVa. Two isolates were not typeable (NT). PVL genes were carried by 
88% of the MRSA isolates, including the SCCmec IVc/IVa and SCCmec I isolates. SCCmec IV caused 
both community-acquired infection (CAI) (47%) and nosocomial infection (HAI) (53%). SCCmec IV, 
PVL-positive MRSA was associated with both CAI (47%) and HAI (53%) and caused mostly SSTI and 
osteoarticular infection.
Conclusions: These findings suggest that the presence of community-associated MRSA (CA-MRSA) 
(SCCmec IV and PVL positive) causes both health care-associated infection (HCAI) and nosocomial 
infection (HAI) in pediatric patients in Colombia.
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Staphylococcus aureus resistente a meticilina causante de infecciones comunitarias y de 
infecciones asociadas a la atención en salud en pacientes pediátricos del Hospital Universitario 
de Santander
Introducción. Staphylococcus aureus resistente a la meticilina (SARM) es un agente frecuente de 
infección en la población pediátrica. Aunque inicialmente las cepas de SARM estaban restringidas a los 
hospitales, se han reportado a nivel mundial brotes de infección por SARM en individuos sin factores 
de riesgo y, actualmente, SARM es una causa frecuente de infecciones hospitalarias y comunitarias.
Objetivo. Describir la relación entre las características moleculares de aislamientos de SARM 
(casete cromosómico estafilocócico mec SCCmec y leucocidina Panton-Valentine) y el origen de la 
infección y su presentación clínica en pacientes pediátricos del Hospital Universitario de Santander 
en Bucaramanga, Colombia.
Materiales y métodos. Se incluyeron 43 aislamientos de SARM obtenidos de niños hospitalizados. 
La clasificación del SCCmec (I-V) y la subclasificación del SCCmec-IV se realizaron en todos los 
aislamientos. Además, los genes de la leucocidina Panton-Valentine se detectaron mediante 
amplificación por PCR. Las características moleculares fueron asociadas con las características 
clínicas de cada paciente.
Resultados. Entre los 43 SARM tipificados, el SCCmec-IVc fue el más frecuente con 77 %, seguido por el 
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SCCmec-I con 16 % y el SCCmec-IVa con 2 %. Tres aislamientos no pudieron ser tipificados. Los genes 
de la leucocidina Panton Valentine se detectaron en 88 % de los SARM en aislamientos portadores del 
SCCmec-IVc/IVa y el SCCmec-I. Los SARM SCCmec-IV positivos para la leucocidina Panton-Valentine  
se asociaron con infecciones adquiridas en la comunidad (47 %) y en el hospital (53 %) con compromiso 
de piel y tejidos blandos, y en los casos más graves, con compromiso osteoarticular.
Conclusiones. Estos resultados sugieren la presencia de cepas SARM-CO (SCCmec-IV positiva para 
PVL) causantes de infecciones adquiridas en la comunidad y en el medio hospitalario en pacientes 
pediátricos en Colombia.
Palabras clave: Staphylococcus aureus resistente a meticilina, pacientes, niño. 
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Staphylococcus aureus is responsible for infections 
ranging from skin and soft tissue infections to 
severe diseases, such as endocarditis, bacteremia, 
necrotizing pneumonia and osteomyelitis (1). 
Methicillin resistance is encoded by the mecA gene, 
which is carried in the staphylococcal cassette 
chromosome mec (SCCmec) (2,3). Based on the 
class of the mec complex, ccr type and composition 
of the J regions, eight types of SCCmec, called I-XI, 
have been described (4,5).
For many years, methicillin-resistant S. aureus 
(MRSA) was restricted to hospitals, causing infec-
tions associated with the health care setting 
(HAI) (6). However, since the early 2000s, 
outbreaks of community-associated MRSA (CA-
MRSA) have been reported worldwide in diverse 
community populations (7,8). Recently, several 
reports described the spread of CA-MRSA in the 
hospital setting, which is beginning to replace 
typical hospital-associated MRSA (HA-MRSA), 
especially in the United States and Taiwan, where 
CA-MRSA prevalence is very high (9). CA-MRSA 
has been reported to be causing infections in 
Latin American countries, such as Brazil (10), 
Uruguay (11), Colombia (12) and Argentina (13). In 
Colombia, CA-MRSA isolates have recently been 
reported to be causing HAI in hospitals in Bogotá 
and Bucaramanga (12,14).
Phenotypic and molecular differences between 
HA- and CA-MRSA have been described, as follows: 
i) HA-MRSA strains carry SCCmec types I-III (15), 
whereas CA-MRSA strains carry SCCmec IV and 
V (16,17); ii) HA-MRSA tends to be multiresistant, 
whereas CA-MRSA tends to be susceptible to narrow-
spectrum non-beta-lactams, such as clindamycin, 
trimethoprim-sulfamethoxazole and tetracyclines 
(18); and iii) a high percentage of CA-MRSA strains 
carry the genes lukS-PV and lukF-PV, encoding 
Panton-Valentine leukocidin (PVL) (18), an important 
virulence factor that has been associated with skin 
abscesses and necrotizing pneumonia (19-21). 
The PVL genes are present in CA-MRSA strains 
with a frequency >75% and are largely absent 
from HA-MRSA strains (7,22-23). In the present 
study, we characterized the relationships between 
the molecular features (SCCmec type and PVL 
carriage) and the characteristics (the origin and 
localization of infection) of infection in pediatric 
patients at the Hospital Universitario de Santander 
in Bucaramanga, Colombia.
Materials and methods
Clinical isolates 
MRSA isolates were obtained from isolated 
cases of local or systemic infections in a pediatric 
population (age range: 0-13 years old), who were 
hospitalized in a third-level university hospital. 
The isolates were collected in the Clinical 
Laboratory of the Hospital Universitario de 
Santander in Bucaramanga, Colombia, during 
the period from March 2007 to March 2009. The 
antibiotic susceptibilities of the S. aureus isolates 
were assessed in accordance with Clinical and 
Laboratory Standards Institute (CLSI) guidelines 
(24). The antibiotics tested included erythromycin, 
clindamycin, ciprofloxacin, gentamicin, tetracycline, 
oxacillin, rifampicin, vancomycin and  trimethoprim-
sulfamethoxazole. Clinical and epidemiological 
information was obtained from the medical records 
of each patient. Each MRSA infection was 
classified as a community-associated infection 
(CAI), nosocomial infection (HAI) or health care-
associated infection (HCAI), according to the 
following definitions:
- CAI: Clinical condition and isolation of MRSA 
within 48 hours of hospitalization in the absence of 
risk factors.
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- HAI: No obvious clinical disease at admission, 
isolation of MRSA after 72 hours of hospitalization 
or presence of risk factors (use of invasive devices, 
surgery, dialysis and previous hospitalization in the 
last three months).
- HCAI: Clinical condition and isolation of MRSA at 
admission or within 48 hours of hospitalization and 
presence of risk factors (25).
Detection of nuc and mecA genes
All isolates were confirmed as MRSA by PCR 
amplification of the nuc and mecA genes according 
to a previously described protocol (26,27).
SCCmec typing and PVL gene detection 
The SCCmec type (I-V) was determined based on 
combinations of the mec complex and ccr type using 
independent PCRs. SCCmec IV subtypes were 
identified using a multiplex PCR under reported 
conditions (28). Amplification of the PVL genes 
(lukS/F PV) was performed as previously reported 
(20). The COL, N315, MW2, E-MRSA-16 and 
RN4220/pG01 strains were included as reference 
strains and were supplied by the Network on 
Antimicrobial Resistance in S. aureus (NARSA).
Ethics statement
The research and informed consent protocols 
were approved by the Ethics Committee at the 
Universidad Industrial de Santander in accordance 
with the ethical standards of the 1964 Declaration 
of Helsinki (Acta No. 15 27/08/2007). Each child’s 
parents or guardians provided written informed 
consent for the review of medical information, and 
all of the information was confidential.
Results
In the period between March 2007 and March 2009, 
there were 126 S. aureus infections in pediatric 
patients, of which 42% were caused by MRSA. In 
total, 8% of the children were aged <1 month; 40%, 
from 1-24 months; 35%, from 2-10 years old, and 
17%, >10 years old.
In this study, 43 non-duplicated MRSA isolates 
were included. Most of the MRSA isolates were 
susceptible to the majority of the antibiotics 
tested; only one isolate presented a multiresistant 
phenotype (resistant to four antibiotics). In total, 44% 
(19/43) of the MRSA isolates exhibited resistance 
to tetracycline; 42% (18/43), to erythromycin; 30% 
(13/43), to ciprofloxacin; 26% (11/43), to clindamycin; 
19% (8/43), to gentamicin, and 5% (2/43), to TMP-
SMX. All strains were resistant to oxacillin and 
susceptible to vancomycin and rifampicin.
SCCmec typing and PVL gene detection
The type SCCmec IVc was the most frequent 
in MRSA clinical isolates (77%, 33 isolates). 
Additionally, 2% (1 isolate) was SCCmec type IVa, 
and 16% (7 isolates) were type I. Two isolates 
were not typeable (NT) following the search for 
the five SCCmec types. The lukS/F PV genes 
were detected in 88% (38/43) of the MRSA isolates 
and were present in all SCCmec types identified. 
The lukS/F PV genes were detected in 100% (1/1) 
and 91% (30/33) of the SCCmec type IVa and 
SCCmec type IVc isolates, respectively. Most of 
the SCCmec type I isolates carried the lukF/S PV 
genes (86%, 6 isolates).
Clinical analysis
Among the infections, 46% were CAIs, 19% were 
HCAIs, and 35% were HAIs (table 1). 
The most frequent clinical manifestation was 
skin infection, affecting 53% (23/43) of pediatric 
patients, followed by soft tissue infection in 28% 
(12/43) and osteoarticular infection in 12% (5/43). 
More severe infections were present at low 
frequencies, such as bacteremia in 5% (2/43) 
and complicated pneumonia in 2% (1/43) (table 
2). Classification was performed according to the 
definitions described before (29).
Expression of the molecular markers SCCmec and 
PVL and the origin of MRSA infection are included 
in table 1. MRSA carrying SCCmec types IVc and 
Table 1. Molecular characteristics of MRSA isolates from community, nosocomial and health care infections 
Molecular marker CAI (n=20)
n (%)
HCAI (n=8)
n (%)
HAI (n=15)
n (%)
Total (n=43)
n (%)
SCC mec 
PVL
Type I
Type IVc
Type IVa
NT
LPV (+)
LPV (-)
  4 (20)
16 (80)
0   
0   
19 (95)
  1  (5)
0
6 (75)
1 (13)
1 (13)
7 (88)
1 (12)
  3 (20)
  11 (73)
0
  1   (7)
12 (80)
  3 (20)
  7 (16)
33 (78)
  1   (2)
  2   (5)
38 (88)
  5 (12)
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IVa and PVL positivity caused CAI, HCAI and HAI 
at high frequencies. In total, 80% of CAIs, 88% of 
HCAIs and 74% of HAIs were caused by isolates 
with SCCmec type IV, and the isolates carrying 
SCCmec type I caused 20% of CAIs and 20% of 
HAIs. SCCmec type IVc and type I isolates that 
were obtained from all localizations were similarly 
PVL-positive isolates, but in a large percentage, 
these isolates were related to skin and soft tissue 
infections (table 2).
Discussion
HCAI and HAI are generally caused by isolates of 
MRSA with the molecular characteristics of HA-MRSA 
strains, such as SCCmec I, the absence of PVL and 
antimicrobial multiresistance patterns. However, 
since the emergence of CA-MRSA strains carrying 
SCCmec IV, the PVL genes and an antimicrobial 
sensitivity pattern phenotype, CA-MRSA isolation in 
hospitals has increased significantly in the United 
States (30,31), in certain European countries, such 
as France (32) and Italy (33), and in Latin American 
countries, including Brazil (10), Argentina (14), 
Uruguay (11) and Colombia (12). In Colombia, for 
the last few years, the presence and circulation of 
CA-MRSA isolates have been described in hospitals 
in different regions, and the prevalence of this strain 
type in the hospital environment has been estimated 
to be approximately 39% (12,34). In our study, 74% 
of HAIs and 88% of HCAIs were caused by isolates 
with the molecular characteristics of CA-MRSA, 
which were higher percentages than previously 
reported (12,34). Therefore, these results confirm 
that CA-MRSA strains have been introduced 
into and have become established in hospitals in 
Colombia. Of the 43 isolates analyzed in our study, 
only seven carried SCCmec I, similar to what has 
been reported in certain European countries such 
as Austria and the United Kingdom, where the 
frequency of HA-MRSA strains in hospitals has 
typically decreased (35).
SCCmec type IV has the greatest variability among 
the SCCmec types (36), and seven subtypes (IVa 
to IVg) have been identified (28). This subtype 
identification has been important for understanding 
the mechanisms of the insertion and acquisition 
of this mobile genetic element and has also been 
used to identify new circulating clones (37). The 
SCCmec subtype IVc was identified for the first 
time in Japan, and this variant was associated with 
HAI (2). Although similar results were observed in 
other countries, such as France (38), in Sweden, 
this subtype has been associated with CAI (39). 
Nevertheless, HAI in countries such as the United 
States and Australia most frequently presents the 
subtype IVa (27). In our study, 77% of the isolates 
were classified as SCCmec IVc, and 2% were 
classified as SCCmec IVa. Both were present in 
all three types of infection. This result supports the 
previous reports of studies in our country, which 
have shown the predominance of the SCCmec 
IVc subtype among isolates, followed by a smaller 
proportion for SCCmec IVa (40,41).
As it has been previously described, most CA-
MRSA isolates are PVL positive (22). Among the 
MRSA isolates tested in our study, 88% carried the 
lukS/F-PV genes, and these genes were detected 
in all SCCmec types identified (SCCmec IVc, 
Iva and I). In Colombia, there have been several 
reports of infections caused by PVL-positive 
MRSA strains carrying SCCmec IVc belonging to 
clonal complex 8 (CC8) in hospitals (13,41-43). 
In a recent previous work, we reported the ST8-
MRSA-IVc clone as the main strain causing HAI 
(13). This finding suggests the possibility that the 
PVL-positive and SCCmec IVc isolates detected 
in our study could be related to the CC8. Despite 
this observation, additional molecular markers 
should be analyzed to confirm the clonal complex 
to which our isolates belonged. In contrast, HA-
MRSA strains (SCCmec type I) usually do not 
Table 2. Molecular characteristics of MRSA isolates and infection type 
Molecular marker Isolate localization / Infection type
SI (n=23)
n (%)
STI (n=12)
n (%)
OAI (n=5)
n (%)
B (n=2)
n (%)
Pn (n=1)
n (%)
SCC mec 
PVL
Type I
Type IVc
Type IVa
NT
LPV (+)
LPV (-)
   4 (17)
 16 (70)
  1   (4)
  2   (9)
20 (87)
  3 (13)
  1   (8)
11 (92)
0    
0    
10 (83)
 2 (17)
  1   (20)
  4   (80)
0     
0     
  5 (100)
0     
  1   (50)
  1   (50)
0     
0     
  2 (100)
0     
0     
  1 (100)
0     
0     
  1 (100)
0     
SI: skin infection; STI: soft tissue infection; OAI: osteo-articular infection; B: bacteremia; Pn: pneumonia
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carry the lukS/F PV genes. However, 80% of HA-
MRSA isolates carried these genes in our hospital 
(13). This finding is interesting because several 
countries report the absence or a low percentage 
of these genes in HA-MRSA isolates. Thus, in 
European countries such as Spain, the United 
Kingdom, France, Italy and Ireland, the PVL genes 
are absent among HA-MRSA isolates (44-46), and 
in a previous study in Colombia, these genes were 
detected in less than 9% of isolates (40). This 
result could reflect a different epidemiology of HA-
MRSA strains in our country, resulting in a high 
frequency of the PVL genes.
Although the role of PVL in the severity of S. 
aureus infection is controversial (47-49), PVL 
production in MRSA has been associated with 
severe skin infections, such as abscesses and 
necrotizing pneumonia. As in a previous report 
that we published (50), in the present study, 
all pediatric patients developed moderate to 
severe infections and had to be treated at a high-
complexity hospital. This finding could be related 
to the observed high frequency of PVL, which was 
greater than 80%.
Therefore, this descriptive study confirms the 
presence of strains with the molecular character-
istics of CA-MRSA, such as SCCmec IV and PVL 
positivity, causing both HCAI and HAI in pediatric 
patients in Colombia. Finally, due to CA-MRSA 
emergence and establishment in hospitals, it is 
necessary to implement control measures and 
appropriate management of infection to prevent 
CA-MRSA dissemination in both hospitals and the 
community environment.
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